Search for: "Janssen Pharmaceutica Products L.P." Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Nov 2010, 6:02 am by Rebecca Tushnet
West Virginia sued J&J and Janssen Pharmaceutica Products, L.P. under the West Virginia Consumer Credit and Protection Act for disseminating false and misleading information to healthcare providers in West Virginia about two drugs, Risperdal (an antipsychotic) and Duragesic (a narcotic pain reliever). [read post]
27 Oct 2021, 5:15 am by Dennis Crouch
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
24 Jun 2010, 5:00 am by Bexis
Playtex Family Products Corp., 168 F.R.D. 292 (D. [read post]
24 Feb 2011, 1:49 pm by Bexis
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
20 Sep 2021, 3:31 pm by Dennis Crouch
Janssen Pharmaceutica (appealing institution denials); Apple Inc. v. [read post]
28 Apr 2011, 3:18 pm by Bexis
  Comment k says unavoidably unsafe products are “especially common” in the context of prescription medical products (actually, it says “drugs” but “medical devices” weren’t recognized as a separate category of products in the early 1960s – the Medical Device Amendments still being more than a decade in the future). [read post]